Open access
138
Views
11
CrossRef citations to date
0
Altmetric
Review
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
Othman Al-SawafGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
, Kirsten FischerGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
, Anja EngelkeGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
, Natali PflugGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
, Michael HallekGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
& Valentin GoedeGerman CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, GermanyCorrespondence[email protected]
Pages 295-304
|
Published online: 25 Jan 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.